The executives, advisors, and directors building the future of neurodegenerative disease interception.
Executive Leadership
The team leading Kivara Neurosciences.
Our executive team brings together scientific depth, operational rigor, and commercial experience to advance the NeuroIntercept™ platform from discovery to clinical impact.
Co-Founder & Chief Executive Officer
Jenna Anderson
Jenna Anderson is an entrepreneur and healthcare executive with experience building and scaling innovative healthcare organizations. She has led commercialization initiatives, strategic partnerships, fundraising efforts, and corporate development programs focused on bringing transformative healthcare solutions to market. As Co-Founder and Chief Executive Officer of Kivara Neurosciences, she directs corporate strategy, investor relations, business development, and organizational growth.
Co-Founder & Chief Operating Officer
Robert Mons
Robert Mons is a healthcare entrepreneur and operations executive with expertise spanning diagnostics, healthcare policy, commercialization, strategic growth, and corporate development. He has successfully led initiatives involving research institutions, government stakeholders, investors, and commercial partners. As Co-Founder and COO of Kivara Neurosciences, Robert oversees operations, strategic partnerships, fundraising support, business development, and execution of the company's long-term growth strategy.
Chief Scientific Officer
Dr. Clifford Morris
Dr. Clifford Morris is a molecular biologist and translational medicine leader with extensive experience in biomarker discovery, translational research, assay development, and precision diagnostics. He has led multidisciplinary scientific teams focused on developing innovative technologies that enable earlier disease detection and improved patient outcomes. At Kivara Neurosciences, Dr. Morris oversees scientific strategy, biomarker development, clinical research programs, academic collaborations, and translational medicine initiatives focused on neurodegenerative disease.
Board of Directors
Experienced governance and stewardship.
Our Board of Directors brings decades of experience scaling innovative companies across healthcare, life sciences, and technology.
Chairman of the Board
Scott Blum
Scott Blum is an accomplished entrepreneur, investor, and executive with extensive experience building and scaling high-growth companies. Throughout his career, he has successfully founded, led, and advised numerous organizations across technology, healthcare, and consumer sectors. As Chairman, Scott provides strategic guidance on corporate growth, governance, capital formation, and long-term value creation.
Director
Parker Kelley
Parker Kelley is an experienced business executive and investor with expertise in strategic growth, corporate finance, and operational leadership. He has advised and supported emerging companies through critical stages of expansion, fundraising, and commercialization. At Kivara Neurosciences, he contributes expertise in corporate strategy, governance, and business development.
Director
Cameron Gray
Cameron Gray is an entrepreneur, investor, and business strategist with experience supporting innovative healthcare and life sciences ventures. His background includes venture investing, strategic partnerships, and scaling early-stage companies. He provides guidance on growth strategy, market positioning, and long-term corporate development.
Join Us
Building the Future of Neurological Health
Kivara Neurosciences is advancing a new generation of diagnostic technologies focused on the earlier detection and monitoring of neurodegenerative disease. We actively collaborate with researchers, clinicians, institutions, strategic partners, and investors who share our mission of improving outcomes for patients worldwide.
